Article Text

Download PDFPDF

FRI0593 Association of thymoma with autoimmune diseases in a series of 83 cases
  1. A González García1,
  2. WA Sifuentes Giraldo2,
  3. JL Morell Hita2,
  4. JL Patier de la Peña1
  1. 1Internal Medicine
  2. 2Rheumatology, Ramon y Cajal University Hospital, Madrid, Spain


Background Thymoma is the most common neoplasm originated from the thymus gland and accounting for 50% of anterior mediastinal tumors. Within its clinical manifestations are included the loss of self-tolerance and the development of autoimmunity.

Objectives To study the frequency of autoimmune diseases (AD) in patients with thymoma and to describe their clinical characteristics and outcome.

Methods We performed a retrospective observational study of a cohort of patients diagnosed with thymoma and followed-up in our center between January 1985 and September 2016. The variables evaluated included demographics, thymoma characteristics, clinical and analytical manifestations of autoimmunity, treatment and outcome.

Results A total of 83 patients were included, 56.6% of them women, with a mean age at diagnosis of the thymoma of 58.4±15.8 years (range: 16–94), 31.3% of which corresponded to type I The classification of Masaoka, 39.1% to II, 17.2% to III and 10.9% to IV. There were one or more AD associated in 41 cases (49.4%). The most frequent diagnoses were myasthenia gravis (19), systemic lupus erythematosus (SLE) (4), subacute cutaneous lupus erythematosus (1), Sjögren's syndrome (1), rheumatoid arthritis (1), spondyloarthritis (1), sarcoidosis (1), hemolytic anemia (2), pernicious anemia (1), aplastic anemia (1), cutaneous limited systemic sclerosis (1), urticaria-vasculitis, erythroblastopenia (1), recurrent pericarditis (1), thyroid disease (2) and lichen planus (1). The diagnosis of AD preceded to thymoma in 38.2% of cases and was later in the remaining cases. In 4 cases there was also a concomitant primary immunodeficiency (variable common immunodeficiency 3, CD4 immunodeficiency 1). The most frequently identified autoantibodies were anti-acetylcholine receptor (14/41, 34.1%), anti-striated muscle (3/41, 7.3%), ANA (11/41, 26.8%), (3/41, 7.3%), rheumatoid factor (3/41, 7.3%), anti-thyroid (3/41, 7.3%), antiphospholipids (2/41, 9%) and anticentromere (1/41, 2.4%). In the comparison of patients with and without associated AD, no significant differences were found regarding age, sex or Masaoka classification. There were 6 deaths, 4 in group with associated AD and 2 in the group without AD, but without significant difference (p=0.3797).

Conclusions In the analyzed population of patients with thymoma of our center, almost half of them developed AD, which in a major group preceded the diagnosis of neoplasia. The spectrum of autoimmunity associated with thymoma was quite broad, including organ-specific AD such as myasthenia gravis (which is most frequently described in the literature) and autoimmune cytopenias, but also to systemic AD, the most common being SLE. The autoimmunity study should be included in the assessment of the patient with thymoma as it could contribute to the early diagnosis of associated AD.

Disclosure of Interest None declared

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.